Skip to content

Prevalence and characteristics of Venous thromboembolism in patients of severe exacerbation of COPD

Prevalence and characteristics of Venous thromboembolism in patients of severe exacerbation of chronic obstructive pulmonary disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029073
Enrollment
156
Registered
2020-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Control Intervention1: nil: nil

Sponsors

AIIMS RISHIKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Consecutive patients admitted with the diagnosis of severe Acute Exacerbation of COPD. 2.Able to give informed consent. 3.Age between 40- 70 years 4. Severe AE-COPD will be defined as an event in the natural course of the disease characterised by a change in the patientâ??s baseline dyspnoea, cough, and/or sputum production that is beyond the normal day-to-day variations, acute in onset, and with sufficient severity warranting admission in the hospital.(GOLD guidelines 2018)

Exclusion criteria

Exclusion criteria: 1.Admission because of reasons other than disease severity (distance, humanitarian concerns, etc.) 2.Not ready to give informed consent, 3.Pregnancy 4.Unfit to undergo CTPA because of impaired renal function or iodine allergy 5.Ongoing anticoagulant treatment for previous VTE or any other indication 6.Known hypercoagulable states like Protein C, S or AT deficiency or Factor V Leiden mutation. Associated malignancy, left sided heart failure, or a debilitating neurological disease

Design outcomes

Primary

MeasureTime frame
prevalence of DVT or PE or both in AE-COPD.Timepoint: at baseline

Secondary

MeasureTime frame
1.Radiological 2.Clinical characteristics 3.Echo characteristics 4.short term outcomesTimepoint: short term outcomes-0,3,6 months Rest at baseline

Countries

India

Contacts

Public ContactDr Ruchi Dua

AIIMS RISHIKESH

ruchi.pulm@aiimsrishikesh.edu.in7895973469

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026